Breaking Science Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breaking Science Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breaking Science Session Today - Breaking & Trending Today

AMGEN PRESENTS NEW PHASE 2 DATA THAT SHOW OLPASIRAN DELIVERS SIGNIFICANT REDUCTION IN LIPOPROTEIN(A) LEVELS

Published: November 7, 2022

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today presented end-of-treatment data from its Phase 2 OCEAN(a)-DOSE study of investigational olpasiran (formerly AMG 890)...

Source: prnewswire.com

Related Topics:

Puerto RicoUnited StatesColl CardiolMichael StrapazonJessica AkopyanMichellel OdonoghueClin LipidolArterioscler Thromb VascDavidm ReeseAmerican Heart Association Scientific SessionsScience Session Of The American Heart AssociationTherapeutics IncTeneobio IncKyowa Kirin Co LtdDrug AdministrationBeigene LtdMost Sustainable CompaniesExchange CommissionStudy Group At BrighamChemocentryx IncOlpasiran Reduced LipoproteinMore ThanPatients With EstablishedOutcomes Trial BasedSimultaneously Published

AMGEN PRESENTS NEW REPATHA® (EVOLOCUMAB) DATA AT AHA 2022

Published: November 7, 2022

Very low LDL-C Levels Data Reinforces Long-Term Efficacy and Consistent Safety Profile of Repatha Observed in FOURIER-OLE THOUSAND OAKS, Calif., N...

Source: businessinsider.com

Related Topics:

Puerto RicoUnited StatesMichael StrapazonJessica AkopyanAmgen MedinfoAmerican Heart Association Scientific SessionsScience Session Of The American Heart AssociationTherapeutics IncJournal Of The American College CardiologyEuropean UnionTeneobio IncKyowa Kirin Co LtdAmerican College Of CardiologyWorld Health OrganizationDrug AdministrationMost Sustainable CompaniesBeigene LtdExchange CommissionChemocentryx IncReinforces Long Term EfficacyConsistent Safety ProfileRepatha ObservedBreaking Science SessionAmerican Heart AssociationScientific Sessions